Sales decline 25.74% to Rs 14.22 crore
Net profit of Bharat Immunological & Biological Corporation reported to Rs 1.93 crore in the quarter ended June 2021 as against net loss of Rs 0.78 crore during the previous quarter ended June 2020. Sales declined 25.74% to Rs 14.22 crore in the quarter ended June 2021 as against Rs 19.15 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales14.2219.15 -26 OPM %7.383.29 -PBDT0.14-1.04 LP PBT0.08-1.10 LP NP1.93-0.78 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
